{
  "title": "Paper_953",
  "abstract": "pmc Sensors (Basel) Sensors (Basel) 1660 sensors sensors Sensors (Basel, Switzerland) 1424-8220 Multidisciplinary Digital Publishing Institute  (MDPI) PMC12473519 PMC12473519.1 12473519 12473519 41013096 10.3390/s25185858 sensors-25-05858 1 Article Cross-Scanner Harmonization of AI/DL Accelerated Quantitative Bi-Parametric Prostate MRI † https://orcid.org/0000-0003-0403-1501 Malyarenko Dariya Conceptualization Methodology Validation Formal analysis Investigation Writing – original draft Project administration 1 * https://orcid.org/0000-0002-4714-4031 Swanson Scott D. Conceptualization Formal analysis Resources Writing – original draft 1 Richardson Jacob Resources Data curation Writing – review & editing 1 Lowe Suzan Investigation Resources Data curation 1 O’Connor James 1 https://orcid.org/0000-0002-0713-9641 Jiang Yun Investigation Resources Writing – review & editing 1 Chahine Reve Validation Formal analysis Writing – review & editing 1 Wells Shane A. Conceptualization Methodology Validation Formal analysis Data curation Writing – review & editing Visualization 1 2 ‡ Chenevert Thomas L. Conceptualization Methodology Software Formal analysis Writing – original draft Supervision 1 ‡ Marcon Marco Academic Editor 1 2 * dariya@umich.edu † This article is a revised and expanded version of Harmonization of AI/DL accelerated quantitative bi-parametric prostate MRI: demonstration in multiparametric phantom and patients. PP103. In Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Honolulu, HI, USA, 10–15 May 2025. ‡ These authors contributed equally to this work and share co-senior authorship. 19 9 2025 9 2025 25 18 497667 5858 05 8 2025 12 9 2025 17 9 2025 19 09 2025 27 09 2025 29 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ Clinical application of AI/DL-aided acquisitions for quantitative bi-parametric (q-bp)MRI requires validation and harmonization across vendor platforms. An AI/DL-accelerated q-bpMRI, including 5-echo T 2 2 2 2 2 2 2 2 bi-parametric MRI apparent diffusion coefficient (ADC) T 2 relaxation quantitative parameter mapping AI/DL-accelerated image reconstruction multi-vendor harmonization prostate imaging reporting data systems (PIRADS) National Institute of Health 75N91021C00036 U01CA211205 R01CA190299 University of Michigan Basic Radiologic Sciences Funding support from National Institute of Health Grants: 75N91021C00036, U01CA211205, R01CA190299, and the University of Michigan Basic Radiologic Sciences innovative research award. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1. Introduction Current clinical management of patients with prostate cancer (PCa) relies on costly and painful multi-core needle biopsies performed for both diagnosis and active surveillance. Due to the relatively low occurrence of high-risk cancers, 80–90% PCa patients could potentially be spared unnecessary biopsies [ 1 2 3 4 5 6 2 7 2 5 8 Imaging studies that add assessment of quantitative diffusion parameter [ 8 9 10 2 11 12 13 8 9 14 2 12 13 14 15 8 10 11 12 15 16 17 14 18 19 5 8 14 2 5 6 9 14 Emerging artificial intelligence (AI) deep learning (DL) reconstruction and denoising methods hold potential to substantially accelerate bpMRI and improve image quality [ 20 21 22 23 24 23 24 23 14 Quantitative validation of the front-end AI/DL-aided reconstruction and image processing provided by scanner vendors is thus particularly challenging and requires a reference platform compatible with the clinical workflow. According to QIBA and FDA guidelines for quantitative imaging devices [ 25 26 27 We have recently developed a quantitative multiparametric phantom for objective bias assessment of relaxation and diffusion parameters in prostate tissue relevant ranges [ 28 2 2. Materials and Methods 2.1. AI/DL-Accelerated Quantitative T 2 The vendor-provided prototype artificial-intelligence (AI) deep-learning (DL) reconstruction and denoising methods [ 20 21 2 29 12 2 Table 1 Table 1 2.2. Patient Studies The prospective, single-center study was IRB-approved and HIPAA-compliant. Informed consent was obtained from all participants. The AI/DL-accelerated protocols were added to SOC exams for six patients (enrolled June–December 2024) on active surveillance for PCa with lesion pathologic grade initially obtained by needle biopsy [ 3 Table 1 30 2 31 32 2.3. Phantom Measurements A previously developed multiparametric phantom consisting of four physical layers of hydrogels providing tissue-mimicking ADC, kurtosis (K), and T 2 Supplementary Figure S1B 28 Supplementary Table S1 28 2 Supplementary Figures S1 and S2 16 2 11 2 28 Supplementary Figure S1 28 Supplementary Table S2 2 2.4. Quantitative Bi-Parametric (bp) MRI Analysis ADC(4b) and MESE-T 2 2 2 2 The T 2 12 (1) l o g ( S T E S 0 ) = − T E T 2 TE (2) l o g ( S b 800 / S b 100 ) = − Δ b × A D C S b 800 S b 100 b 2 (3) l o g ( S b / S 0 ) = − b × A D C + K × ( b × A D C ) 2 / 6 K S b S 0 2.5. Phantom Metrics and Protocol Bias Measurement Phantom T 2 Supplementary Figure S2 2 2 2 26 27 Bias ( T 2 or ADC T 2 or ADC T 2 or ADC (4) The phantom bias dependence on measured parameter value for patient AI/DL-aided quantitative T 2 ADC ADC T 2 p T 2 ADC 2.6. Quantitative Lesion Metrics Harmonization Lesion ROIs were manually traced on a single slice of each patient’s ADC(4b) maps to avoid artifacts and partial volume. The same ROI was applied for all ADC and T 2 2 2 2 2 2 3. Results 3.1. Qualitative Assessment The AI/DL accelerated four-b DWI and five-TE T 2 Table 1 Table 1 2 2 2 2 2 Four MRI visible lesions were subjectively evaluated by two raters on a 4-pt Likert-like scale for AI/DL-aided reconstruction protocols in comparison to SOC for diagnostic quality, contrast, SNR, resolution, and distortion ( Table 2 Figure 1 Table 2 For DWI b1600 Figure 2 Table 2 Figure 2 3.2. Quantitative Assessment Figure 3 Supplementary Figure S2 Supplementary Figure S2 Table 3 Supplementary Tables S3 and S4 Over the reference T 2 Figure 3 2 2 2 Supplementary Figure S3 2 2 Figure 3 Supplementary Figure S3 Table 1 Table 3 Supplementary Table S3 2 Supplementary Table S4 2 2 Supplementary Table S4 ADC(4b) model bias ( Figure 3 Supplementary Figure S1B 2 Supplementary Table S3 p p 2 Figure 3 Supplementary Table S4 The precision (histogram peak HW) and SNR are apparently similar to those of the DK phantom reference ( Table 3 Figure 3 2 2 2 Table 3 Figure 3 2 2 2 It is noteworthy that AI/DL-aided reconstruction for phantom scans mainly affected precision (HW) and SNR, while absolute bias was due to acquisition protocol (T 2 3.3. Quantitative bpMRI Harmonization The use of measured protocol biases ( Figure 3 Table 3 2 Figure 4 2 Figure 1 2 Figure 4 2 2 2 2 2 Table 4 Figure 4 2 After bias correction, the harmonized T 2 Table 4 2 2 2 2 Figure 5 2 2 2 Table 4 Phantom multiexponential diffusion materials allow evaluation of ADC dependence on b-value ( Supplementary Figure S1 Supplementary Figure S1, Tables S3 and S4 Figure 5 Figure 3 Figure 5 2 2 2 Figure 5 Supplementary Figure S1A 4. Discussion AI/DL accelerated acquisition [ 20 21 6 8 9 14 2 in vivo 2 26 33 34 10 35 Our study confirmed the benefits of AI/DL accelerated bpMRI for prostate imaging [ 20 21 32 36 2 20 21 22 32 36 Much of the current research on multi-system harmonization of bi-parametric prostate MRI has been focused on downstream lesion segmentation and classification analysis in retrospective studies [ 37 38 39 40 41 42 14 24 27 37 38 41 42 26 33 34 37 38 41 42 14 25 27 43 14 24 27 43 23 26 27 22 32 36 44 The present prospective study implements the recommended harmonization approach [ 26 27 33 34 28 23 26 2 2 2 2 10 2 2 10 31 Our study had several limitations. The tests were performed on two systems with a small number of MR-visible low-grade lesions and a two-reader assessment. This may potentially increase the variability of qualitative scores for subjective evaluation, although we observed good inter-reader agreement and consistency with quantitative phantom SNR evaluation. Larger population, multi-system, multi-reader studies with correlation to clinical outcomes (including high and low PCa grades) are needed to ascertain the added benefit of the AI/DL-accelerated q-bpMRI protocols for PCa patient management [ 14 23 36 20 21 31 36 2 Harmonization was based on the correction of additive bias for mean ROI metrics, which do not affect voxel-based image texture features and histograms used for radiomics analysis [ 40 41 42 2 2 45 46 2 1 in vivo 2 5. Conclusions The developed protocol enables harmonization of the vendor-provided AI/DL-accelerated acquisition options to establish credibility and streamline implementation of prostate q-bpMRI protocols in a multi-vendor clinical environment. AI/DL-aided reconstruction reduces acquisition time with improved SNR and resolution versus the SOC protocol. A multiparametric phantom allows assessment of biases directly for clinical scan protocols with arbitrary acquisition settings on a per-patient basis. The observed biases were due to acquisition parameters for T 2 2 Acknowledgments We acknowledge the support of clinical research coordinator, Sarah Culver, for patient scheduling and consenting to the IRB for MR technology development. We are thankful to MRI technologist, Jesus E Fajardo, and vendor representatives, Nig Jin and Ramin Jafari, for their help with the initial implementation of WIP DL/AI protocols on clinical 3T systems. Disclaimer/Publisher’s Note: Supplementary Materials The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/s25185858/s1 2 Table 1 2 2 2 2 2 2 Figure 3 2 Figure 3 https://data.nist.gov/od/id/mds2-2366 2 2 2 28 30 46 47 Author Contributions Conceptualization, D.M., S.D.S. and T.L.C.; methodology, D.M., S.A.W., Y.J. and T.L.C.; scan-protocol implementation, D.M., S.D.S., J.R. and S.L.; data acquisition, J.R., S.L. and J.O.; software, D.M. and T.L.C.; validation, S.A.W., R.C. and T.L.C.; formal analysis, D.M., S.A.W., R.C., and S.D.S.; resources, D.M., S.D.S. and Y.J.; data curation, D.M., S.A.W., J.R., S.L., J.O. and T.L.C.; writing—original draft preparation D.M., S.D.S. and T.L.C.; writing—review and editing, all authors; visualization, D.M., S.A.W. and T.L.C.; supervision, D.M., S.D.S. and T.L.C.; project administration, D.M., Y.J. and J.R.; funding acquisition, internal funding to D.M. and Y.J. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement The Institutional Review Board approved the study (IRB protocol # HUM 00175599, approved on 20 March 2024). Informed Consent Statement Informed consent was obtained from all subjects involved in the study. Data Availability Statement Essential data is contained in the article and Supplementary Figures. Conflicts of Interest S.D.S., T.L.C., and D.M. are co-inventors of diffusion kurtosis phantom IP, assigned to and managed by the University of Michigan. Abbreviations The following abbreviations are used in this manuscript: ADC Apparent diffusion coefficient QIBA Quantitative Imaging Biomarker Alliance NIST National Institute of Standards DWI Diffusion weighted imaging T2w T2 weighted DLpf Deep-learning partial-Fourier AIsr Artificial-intelligence super-resolution q-bpMRI Quantitative bi-parametric MRI SOC Standard-of-care MESE Multi-Echo Spin-Echo MEEPI Multi-Echo echo-planar imaging TE Echo-time DK Diffusion kurtosis HW Half-width Sys system pt patient PVP polyvinylpyrrolidone References 1. Ferro M. Crocetto F. Bruzzese D. Imbriaco M. Fusco F. Longo N. Napolitano L. La Civita E. Cennamo M. Liotti A. Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer Cancers 2021 13 4723 10.3390/cancers13184723 34572950 PMC8466029 2. Schoots I.G. Barentsz J.O. Bittencourt L.K. Haider M.A. Macura K.J. Margolis D.J.A. Moore C.M. Oto A. Panebianco V. Siddiqui M.M. PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review AJR Am. J. Roentgenol. 2021 216 3 19 10.2214/AJR.20.24268 32812795 3. Shankar P.R. Maturen K.E. George A.K. Borza T. Ellimoottil C. Montgomery J.S. Wei J.T. Denton B.T. Davenport M.S. Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients J. Am. Coll. Radiol. 2019 16 1385 1392 10.1016/j.jacr.2018.11.031 30733160 4. Purysko A.S. Rosenkrantz A.B. Barentsz J.O. Weinreb J.C. Macura K.J. PI-RADS Version 2: A Pictorial Update Radiographics 2016 36 1354 1372 10.1148/rg.2016150234 27471952 5. Barkovich E.J. Shankar P.R. Westphalen A.C. A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores AJR Am. J. Roentgenol. 2019 212 847 854 10.2214/AJR.18.20571 30807218 6. Tavakoli A.A. Hielscher T. Badura P. Gortz M. Kuder T.A. Gnirs R. Schwab C. Hohenfellner M. Schlemmer H.P. Bonekamp D. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer Radiology 2023 306 186 199 10.1148/radiol.212692 35972360 7. Tan C.H. Hobbs B.P. Wei W. Kundra V. Dynamic contrast-enhanced MRI for the detection of prostate cancer: Meta-analysis AJR Am. J. Roentgenol. 2015 204 W439 W448 10.2214/AJR.14.13373 25794093 PMC5152763 8. Meyer H.J. Wienke A. Surov A. Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient—A systematic review and meta analysis BMC Cancer 2020 20 482 10.1186/s12885-020-06942-x 32460795 PMC7254689 9. Moraes M.O. Roman D.H.H. Copetti J. de S Santos F. Agra A. Noronha J.A.P. Carvalhal G. Neto E.J.D. Zanon M. Baldisserotto M. Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer World J. Urol. 2020 38 981 991 10.1007/s00345-019-02827-2 31175458 10. Nguyen T.B. Ushinsky A. Yang A. Nguyentat M. Fardin S. Uchio E. Lall C. Lee T. Houshyar R. Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer Br. J. Radiol. 2018 91 20180091 10.1259/bjr.20180091 29869921 PMC6209473 11. Hoang Dinh A. Souchon R. Melodelima C. Bratan F. Mege-Lechevallier F. Colombel M. Rouviere O. Characterization of prostate cancer using T2 mapping at 3T: A multi-scanner study Diagn. Interv. Imaging 2015 96 365 372 10.1016/j.diii.2014.11.016 25547670 12. Devine W. Giganti F. Johnston E.W. Sidhu H.S. Panagiotaki E. Punwani S. Alexander D.C. Atkinson D. Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T(2) MR Images J. Magn. Reson. Imaging 2019 50 910 917 10.1002/jmri.26608 30566264 PMC6767562 13. Panda A. O’Connor G. Lo W.C. Jiang Y. Margevicius S. Schluchter M. Ponsky L.E. Gulani V. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping Investig. Radiol. 2019 54 485 493 10.1097/RLI.0000000000000569 30985480 PMC6602844 14. Margolis D.J.A. Chatterjee A. deSouza N.M. Fedorov A. Fennessy F.M. Maier S.E. Obuchowski N. Punwani S. Purysko A. Rakow-Penner R. Quantitative Prostate MRI, From the AJR Special Series on Quantitative Imaging AJR Am. J. Roentgenol. 2024 225 e2431715 10.2214/AJR.24.31715 39356481 PMC11961719 15. Chatterjee A. Mercado C. Bourne R.M. Yousuf A. Hess B. Antic T. Eggener S. Oto A. Karczmar G.S. Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings Radiology 2022 302 368 377 10.1148/radiol.2021204459 34751615 PMC8805656 16. Hectors S.J. Semaan S. Song C. Lewis S. Haines G.K. Tewari A. Rastinehad A.R. Taouli B. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study Radiology 2018 286 918 928 10.1148/radiol.2017170904 29117481 17. Panagiotaki E. Chan R.W. Dikaios N. Ahmed H.U. O’Callaghan J. Freeman A. Atkinson D. Punwani S. Hawkes D.J. Alexander D.C. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging Investig. Radiol. 2015 50 218 227 10.1097/RLI.0000000000000115 25426656 18. Hurrell S.L. McGarry S.D. Kaczmarowski A. Iczkowski K.A. Jacobsohn K. Hohenwalter M.D. Hall W.A. See W.A. Banerjee A. Charles D.K. Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging J. Med. Imaging 2018 5 011004 10.1117/1.JMI.5.1.011004 29098169 PMC5658575 19. Simpkin C.J. Morgan V.A. Giles S.L. Riches S.F. Parker C. deSouza N.M. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume Br. J. Radiol. 2013 86 20120469 10.1259/bjr.20120469 23426849 PMC3635787 20. Gassenmaier S. Afat S. Nickel D. Mostapha M. Herrmann J. Othman A.E. Deep learning-accelerated T2-weighted imaging of the prostate: Reduction of acquisition time and improvement of image quality Eur. J. Radiol. 2021 137 109600 10.1016/j.ejrad.2021.109600 33610853 21. Ueda T. Ohno Y. Yamamoto K. Murayama K. Ikedo M. Yui M. Hanamatsu S. Tanaka Y. Obama Y. Ikeda H. Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging Radiology 2022 303 373 381 10.1148/radiol.204097 35103536 22. van Lohuizen Q. Roest C. Simonis F.F.J. Fransen S.J. Kwee T.C. Yakar D. Huisman H. Assessing deep learning reconstruction for faster prostate MRI: Visual vs. diagnostic performance metrics Eur. Radiol. 2024 34 7364 7372 10.1007/s00330-024-10771-y 38724765 PMC11519109 23. Lin D.J. Johnson P.M. Knoll F. Lui Y.W. Artificial Intelligence for MR Image Reconstruction: An Overview for Clinicians J. Magn. Reson. Imaging 2021 53 1015 1028 10.1002/jmri.27078 32048372 PMC7423636 24. Vergara D. Armato S.G. Hadjiiski L. 3rd Drukker K. Best Practices for Artificial Intelligence and Machine Learning for Computer-Aided Diagnosis in Medical Imaging J. Am. Coll. Radiol. 2024 21 341 343 10.1016/j.jacr.2023.10.021 37925095 25. Obuchowski N.A. Huang E. deSouza N.M. Raunig D. Delfino J. Buckler A. Hatt C. Wang X. Moskowitz C. Guimaraes A. A Framework for Evaluating the Technical Performance of Multiparameter Quantitative Imaging Biomarkers (mp-QIBs) Acad. Radiol. 2023 30 147 158 10.1016/j.acra.2022.08.031 36180328 PMC9825639 26. US FDA Center for Devices and Radiological Health Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions FDA Silver Spring, MA, USA 2022 Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/technical-performance-assessment-quantitative-imaging-radiological-device-premarket-submissions (accessed on 3 August 2025) 27. Boss M.A. Malyarenko D. Partridge S. Obuchowski N. Shukla-Dave A. Winfield J.M. Fuller C.D. Miller K. Mishra V. Ohliger M. The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker Radiology 2024 313 e233055 10.1148/radiol.233055 39377680 PMC11537247 28. Malyarenko D. Ono S. Lynch T.J.E. Swanson S.D. Technical note: Hydrogel-based mimics of prostate cancer with matched relaxation, diffusion and kurtosis for validating multi-parametric MRI Med. Phys. 2024 51 3590 3596 38128027 10.1002/mp.16908 PMC11138133 29. Dieckmeyer M. Ruschke S. Eggers H. Kooijman H. Rummeny E.J. Kirschke J.S. Baum T. Karampinos D.C. ADC Quantification of the Vertebral Bone Marrow Water Component: Removing the Confounding Effect of Residual Fat Magn. Reson. Med. 2017 78 1432 1441 27851874 10.1002/mrm.26550 30. Malyarenko D. Swanson S.D. Richardson J. Lowe S. O’Connor J. Fajardo J.E. Jiang Y. Wells S. Chenevert T.L. Harmonization of AI/DL accelerated quantitative bi-parametric prostate MRI: Demonstration in multi-parametric phantom and patients Proceedings of the 2025 ISMRM Honolulu, HI, USA 10–15 May 2025 103 31. Lawrence E.M. Zhang Y. Starekova J. Wang Z. Pirasteh A. Wells S.A. Hernando D. Reduced field-of-view and multi-shot DWI acquisition techniques: Prospective evaluation of image quality and distortion reduction in prostate cancer imaging Magn. Reson. Imaging 2022 93 108 114 10.1016/j.mri.2022.08.008 35944809 PMC9523455 32. Bischoff L.M. Peeters J.M. Weinhold L. Krausewitz P. Ellinger J. Katemann C. Isaak A. Weber O.M. Kuetting D. Attenberger U. Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI Radiology 2023 308 e230427 10.1148/radiol.230427 37750774 33. Panetta J.V. Daube-Witherspoon M.E. Karp J.S. Validation of phantom-based harmonization for patient harmonization Med. Phys. 2017 44 3534 3544 10.1002/mp.12311 28464372 PMC5508562 34. Kim H. Thomas J.V. Nix J.W. Gordetsky J.B. Li Y. Rais-Bahrami S. Portable Perfusion Phantom Offers Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Accurate Prostate Cancer Grade Stratification: A Pilot Study Acad. Radiol. 2021 28 405 413 10.1016/j.acra.2020.02.027 32224036 PMC7529802 35. Saito Y. Kamagata K. Andica C. Maikusa N. Uchida W. Takabayashi K. Yoshida S. Hagiwara A. Fujita S. Akashi T. Traveling Subject-Informed Harmonization Increases Reliability of Brain Diffusion Tensor and Neurite Mapping Aging. Dis. 2023 15 2770 2785 10.14336/AD.2023.1020 38029401 PMC11567268 36. Johnson P.M. Tong A. Donthireddy A. Melamud K. Petrocelli R. Smereka P. Qian K. Keerthivasan M.B. Chandarana H. Knoll F. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate J. Magn. Reson. Imaging 2022 56 184 195 10.1002/jmri.28024 34877735 PMC9170839 37. Saha A. Bosma J.S. Twilt J.J. van Ginneken B. Bjartell A. Padhani A.R. Bonekamp D. Villeirs G. Salomon G. Giannarini G. PI-CAI consortium. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): An international, paired, non-inferiority, confirmatory study Lancet Oncol. 2024 25 879 887 10.1016/S1470-2045(24)00220-1 38876123 PMC11587881 38. Giganti F. Moreira da Silva N. Yeung M. Davies L. Frary A. Ferrer Rodriguez M. Sushentsev N. Ashley N. Andreou A. Bradley A. AI-powered prostate cancer detection: A multi-centre, multi-scanner validation study Eur. Radiol. 2025 35 4915 4924 10.1007/s00330-024-11323-0 40016318 PMC12226644 39. Sunoqrot M.R.S. Saha A. Hosseinzadeh M. Elschot M. Huisman H. Artificial intelligence for prostate MRI: Open datasets, available applications, and grand challenges Eur. Radiol. Exp. 2022 6 35 10.1186/s41747-022-00288-8 35909214 PMC9339427 40. Telecan T. Chiorean A. Sipos-Lascu R. Caraiani C. Boca B. Hendea R.M. Buliga T. Andras I. Crisan N. Lupsor-Platon M. ISUP Grade Prediction of Prostate Nodules on T2WI Acquisitions Using Clinical Features, Textural Parameters and Machine Learning-Based Algorithms Cancers 2025 17 2035 10.3390/cancers17122035 40563684 PMC12190648 41. Castaldo R. Brancato V. Cavaliere C. Trama F. Illiano E. Costantini E. Ragozzino A. Salvatore M. Nicolai E. Franzese M. A Framework of Analysis to Facilitate the Harmonization of Multicenter Radiomic Features in Prostate Cancer J. Clin. Med. 2022 12 140 10.3390/jcm12010140 36614941 PMC9821561 42. Hu F. Chen A.A. Horng H. Bashyam V. Davatzikos C. Alexander-Bloch A. Li M. Shou H. Satterthwaite T.D. Yu M. Image harmonization: A review of statistical and deep learning methods for removing batch effects and evaluation metrics for effective harmonization Neuroimage 2023 274 120125 10.1016/j.neuroimage.2023.120125 37084926 PMC10257347 43. Boss M.A. Snyder B.S. Kim E. Flamini D. Englander S. Sundaram K.M. Gumpeni N. Palmer S.L. Choi H. Froemming A.T. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701) J. Magn. Reson. Imaging 2022 56 668 679 10.1002/jmri.28093 35143059 PMC9363527 44. Lemainque T. Yoneyama M. Morsch C. Iordanishvili E. Barabasch A. Schulze-Hagen M. Peeters J.M. Kuhl C. Zhang S. Reduction of ADC bias in diffusion MRI with deep learning-based acceleration: A phantom validation study at 3.0 T Magn. Reson. Imaging 2024 110 96 103 10.1016/j.mri.2024.04.018 38631532 45. Keenan K.E. Peskin A.P. Wilmes L.J. Aliu S.O. Jones E.F. Li W. Kornak J. Newitt D.C. Hylton N.M. Variability and bias assessment in breast ADC measurement across multiple systems J. Magn. Reson. Imaging 2016 44 846 855 10.1002/jmri.25237 27008431 PMC5098898 46. Amouzandeh G. Chenevert T.L. Swanson S.D. Ross B.D. Malyarenko D.I. Technical note: Temperature and concentration dependence of water diffusion in polyvinylpyrrolidone solutions Med. Phys. 2022 49 3325 3332 10.1002/mp.15556 35184316 PMC9090959 47. Holz M. Heil S.R. Sacco A. Temperature-dependent self-diffusion coefficients of water and six selected molecular 16 liquids for calibration in accurate 1H NMR PFG measurements Phys. Chem. Chem. Phys. 2000 2 4740 4742 10.1039/b005319h Figure 1 Gray-scale images qualitatively compare examples of standard of care (SOC) bi-parametric (bp)MRI versus deep-learning partial-Fourier (DLpf) and artificial-intelligence super-resolution (AIsr) from two different vendor 3T systems (Sys1 and Sys2) in two patients (pt1 and pt3) with PIRADS 4 lesions (arrows) in the right anterior mid-gland (pt1, left) and left posterior apex (pt3, right) peripheral zone. Figure 2 Different sensitivity to susceptibility distortions for standard of care (SOC1/SOC2) versus DL/AI accelerated bi-parametric (bp)MRI on two 3T systems (Sys1 and Sys2) for two patients (pt) with peripheral zone PIRADS 5 lesions (arrows) in the right apex (pt2) and left apex (pt4). Figure 3 Quantitative bias assessment for multiparametric phantom scanned with four DL/AI accelerated bpMRI protocols (“Sys1-pt1”, “Sys1-pt2”, “Sys2-pt3”, “Sys2-pt4”, color-coded in the legends) used for patients (pt) with MRI-visible lesions ( Table 1 2 A B Supplementary Figure S2 2 2 Supplementary Figure S3 Supplementary Figure S1 Figure 4 Bi-parametric Sys1-DLpf (top row) and Sys2-AIsr (bottom row) maps (color) and lesion histograms for T 2 2 Figure 3 2 Figure 5 ( A 2 2 B A B sensors-25-05858-t001_Table 1 Table 1 Essential acquisition protocol parameters. Protocol TE (ms) TR (s) b[nav] (s/mm 2 Acquired Voxel (mm 3 Scan Duration (min)  Sys1:       SOC1-T2w 107  * 9.2/4.8 NA 0.5 × 0.6 × 3 6:00  SOC1-DWI 91  4.4/4.8 0[1], 100[1], 800[3], 1600[20] 1.75 × 1.75 × 4 8:50  DLpf-T2 (MEEPI) 40, 70, 100, 130, 160  5.5/6.8 NA 2 × 2 × 3 2:10  DLpf-ADC 80 5.5 0[1], 100[1], 800[2], 1600[8] 2 × 2 × 4/3 3:30  Sys2:       SOC2-T2w 110 4.4 NA 0.4 × 0.7 × 3 5:00  SOC2-DWI 77 7.2 0[2], 100[2], 800[4], 1600[16] 2.2 × 2.3 × 4 8:20  AIsr-T2 (MESE) 25, 65, 105, 145, 185  8/12.2 NA 2 × 2.3 × 3 1:45  AIsr-ADC 77  3.9/5.4 0[1], 100[1], 800[2], 1600[8] 2 × 2 × 3/4 4:00 * Parameters in bold changed between patient scans; TE: echo time; TR: repeat time; [nav]: number of averages per b-value; Sys1: Siemens Vida; Sys2: Philips Ingenia; SOC: standard of care; DLpf: deep-learning partial-Fourier; AIsr: artificial-intelligence super-resolution; MEEPI: multi-echo echo-planer imaging; MESE: multi-echo spin-echo. sensors-25-05858-t002_Table 2 Table 2 Likert-like scores (rater 1/rater 2) for qualitative comparison of SOC versus AI/DL-accelerated bpMRI for patients with MR-visible lesions. Image Eval. Criteria Sys1-pt1 Sys1-pt2 Sys2-pt3 Sys2-pt4  ADC  Dx quality 3/3 2/3 3/4 3/3  distortion 3/3 2/2 4/3 4/4  resolution 3/2 2/2 4/4 4/4  SNR 4/3 2/2 3/4 4/4  median 3/3 2/2 3.5/4 4/4  DWI b1600  Dx quality 3/3 2/2 3/3 4/3  distortion 3/3 2/2 4/3 4/4  resolution 2/2 2/2 4/3 3/4  SNR 4/4 2/2 2/3 4/4  median 3/3 2/2 3.5/3 4/4  T2w  Dx quality 2/2 1/1 3/3 4/3  distortion 2/3 1/2 3/3 3/3  resolution 2/2 2/2 2/2 3/2  SNR 3/2 2/2 4/4 4/4  median 2/2 1.5/2 3/3 3.5/3 Sys-pt: system—patient; ADC: apparent diffusion coefficient; SNR: signal-to-noise ratio; DWI b1600 2 sensors-25-05858-t003_Table 3 Table 3 T 2 Protocol Parameter GS7 nTZ nPZ Atr  DKref (22.0)  ADC ± 0.015 (mm 2 1.06 [0.06] 1.33 [0.06] 1.42 [0.04] 1.72 [0.04]  Sys1-pt1 (21.4) 0.64 [0.04] 0.91 [0.04] 1.03 [0.02] 1.33 [0.02]  Sys1-pt2 (21.1) 0.77 [0.05] 0.92 [0.06] 1.07 [0.06] 1.31 [0.04]  Sys2-pt3 (21.0) 0.79 [0.07] 0.88 [0.06] 1.03 [0.04] 1.36 [0.04]  Sys2-pt4 (23.5) 0.83 [0.05] 0.92 [0.04] 1.07 [0.03] 1.43 [0.03]  T2ref (22.0)  T 2 71 [4] 89 [2] 137 [3] 173 [8]  Sys1-pt1 (21.4) 64 [4] 70 [8] 109 [7] 187 [7]  Sys1-pt2 (21.1) 73 [12] 79 [6] 100 [6] 166 [8]  Sys2-pt3 (21.0) 67 [2] 79 [4] 130 [5] 169 [10]  Sys2-pt4 (23.5) 73 [4] 82 [5] 139 [6] 178 [9] Ts: phantom scan temperature; HW: half-width; GS7: Gleason7, TZ: transition-zone, PZ: peripheral-zone, Atr: atrophy tissue mimics; DKref: diffusion kurtosis reference; Sys-pt: system—patient protocol. sensors-25-05858-t004_Table 4 Table 4 Measured and corrected T 2 Parameter Sys1-pt1 Sys1-pt2 Sys2-pt3 Sys2-pt4  T2meas ± 3 (ms) 90 [25] 76 [20] 110 [10] 82 [16]  T2cor ± 3 (ms) 120 [25] 96 [20] 120 [10] 91 [16]  ADC(4b)meas ± 0.03 (mm 2 0.93 [0.09] 1.01 [0.18] 0.75 [0.24] 0.56 [0.12]  ADC(4b)cor ± 0.03 (mm 2 1.31 [0.09] 1.39 [0.18] 1.11 [0.24] 0.92 [0.12]  ADC(2b)meas ± 0.03 (mm 2 1.18 [0.16] 1.16 [0.31] 0.98 [0.36] 0.77 [0.23]  ADC(2b)cor ± 0.03 (mm 2 1.37 [0.16] 1.35 [0.31] 1.16 [0.36] 0.95 [0.23]  ADC(DK)meas ± 0.03 (mm 2 1.45 [0.2] 1.36 [0.44] 1.2 [0.38] 0.91 [0.24] HW: half-width; Sys-pt: system—patient; meas: measured; cor: corrected; ADC(4b): four b-value ADC fit; ADC(2b): two b-value ADC fit; ADC(DK): diffusion kurtosis ADC fit. ",
  "metadata": {
    "Title of this paper": "Temperature-dependent self-diffusion coefficients of water and six selected molecular 16 liquids for calibration in accurate 1H NMR PFG measurements",
    "Journal it was published in:": "Sensors (Basel, Switzerland)",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12473519/"
  }
}